Merck & Co Inc (MIL:1MRKX)
€ 111.24 -2.12 (-1.87%) Market Cap: 279.07 Bil Enterprise Value: 316.79 Bil PE Ratio: 36.68 PB Ratio: 7.01 GF Score: 58/100

Merck & Co Inc at Investor Event at AIDS Transcript

Aug 03, 2026 / 12:00PM GMT
Operator

(audio in progress) AIDS Conference. (Operator Instructions) This call is being recorded. If you have any objections, you may disconnect at this time.

I would now like to turn the call over to Mr. Peter Dannenbaum, Senior Vice President, Investor Relations. Sir, you may begin.

Peter Dannenbaum
Merck & Co Inc - Senior Vice President, Investor Relations

Thank you, Amanda. Good morning, everyone, and thank you for joining us for Merck's HIV investor event following the 26th International AIDS Conference that took place in Rio de Janeiro, Brazil last week.

Before we get started, I'd like to remind you that some of the statements that we make today may be considered forward-looking statements within the meaning of the safe harbor provision of the US Private Securities Litigation Reform Act of 1995. Such statements are made based on the current beliefs of our company's management and are subject to significant risks and uncertainties. If our underlying assumptions prove inaccurate or uncertainties materialize, actual results may differ

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot